ArticleBMC genomics2025
Phylogenomic insights support the merger of the genera Mameliella and Maliponia into the genus Antarctobacter.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Notification of changes in taxonomic opinion previously published outside theInternational journal of systematic and evolutionary microbiology · 2026Article
- Validation List no. 229: valid publication of new names and new combinations effectively published outside theInternational journal of systematic and evolutionary microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundMembers of the family Roseobacteraceae are metabolically, phenotypically, and genotypically diverse and are widely distributed in global marine environments. This family comprises over 150 validly published genera and nearly 500 validly published species. Despite its widespread use, 16S rRNA gene sequence analysis has proven inadequate for accurately resolving taxonomic relationships within the Roseobacteraceae, resulting in significant inconsistencies in the current classification of this family. Notably, a significant proportion of Roseobacteraceae genera contain only one species, suggesting a potential for over-splitting. To address this issue, we investigated the taxonomic status of three genera, Antarctobacter, Mameliella, and Maliponia, which were originally delineated based on 16S rRNA data.
resultsOur phylogenomic analyses, based on single-copy orthologous clusters and a bacterial core gene set, revealed that species from these three genera form a robust and distinct clade. Furthermore, genome-wide similarity indices, including average amino acid identity (AAI), percentage of conserved proteins (POCP), genome-wide average nucleotide identity (gANI), and alignment fraction (AF), consistently indicated a close relatedness among these genera. Analysis of the available phenotypic features also revealed that species of the genera Antarctobacter,Mameliella and Maliponia are very closely related and lack distinct characteristics.
conclusionsOur findings suggest that Antarctobacter, Mameliella, and Maliponia may represent a single genus. We therefore propose that Mameliella and Maliponia species should be reclassified as members of the genus Antarctobacter. This re-evaluation contributes to the ongoing effort to refine the taxonomy of the Roseobacteraceae, correct historical misclassifications, and reduce the proliferation of underpopulated genera within this ecologically important family. This reclassification provides a more accurate framework for studying the evolution, diversity, and ecological roles of these bacteria, and allows researchers to focus on more significant variations among species. Our results help establish a more reasonable taxonomy within the family Roseobacteraceae.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.